Synapse - Hematologic Malignancies, Division of

Search Within

Hematologic Malignancies, Division of

Results (13379)

Generation of cytomegalovirus-specific T lymphocytes using protein-spanning pools of pp65-derived over-lapping pentadecapeptides for adoptive immunotherapy

Meeting Abstract

Koehne, G.; Trivedi, D.; Williams, R. Y.; O'Reilly, R. J.
Blood (2004)

Fulltext@MSK | Save

Tositumomab and iodine I 131 tositumomab (BEXXAR (R) therapeutic regimen) produces long-term durable responses in heavily pretreated patients with relapsed, refractory, and transformed low-grade non-hodgkin's lymphoma (NHL

Meeting Abstract

Knox, S. K.; Meredith, R. F.; Coleman, M.; Kaminski, M. S.; Zelenetz, A. D.; Vose, J. M.
International Journal of Radiation Oncology, Biology, Physics (2004)

Fulltext@MSK | Save

Clinical course and significance of the novel FLT3-Y842C mutation in a patient with AML treated with PKC412 monotherapy

Meeting Abstract

Kindler, T.; Breitenbuecher, F.; Kasper, S.; Estey, E.; Giles, F.; Feldman, E.; Ehninger, G.; Schiller, G.; Klimek, V.; Nimer, S. D.; more...
Blood (2004)

Fulltext@MSK | Save

Serum IL-12 : IL-6 ratio reliably distinguishes infectious from non-infectious causes of fever during autologous stem cell transplantation (ASCT)

Meeting Abstract

Kewalramani, T.; Tuma, R. A.; Almyroudis, N. G.; Sohn, S.; Rice, R. D.; Galinkin, D.; Blain, M.; Qin, J.; Pamer, E. G.; Nimer, S. D.
Blood (2004)

Fulltext@MSK | Save

Selective depletion of T cell clones responsible for GVHD in a murine model

Meeting Abstract

Kappel, B. J.; Eng, J. M.; Pinilla-Ibarz, J.; van den Brink, M. R. M.; Scheinberg, D. A.
Biology of Blood and Marrow Transplantation (2004)

Fulltext@MSK | Save

Tositumomab and iodine I 131 tositumomab (The BEXXAR (R) therapeutic regimen) produced ongoing, durable remissions of more than 5 years in 9 patients with non-Hodgkin's lymphoma (NHL) in a pivotal study of patients refractory to their last chemotherapy

Meeting Abstract

Kaminski, M. S.; Zelenetz, A. D.; Press, O. W.; Saleh, M. N.; Leonard, J. P.; Fehrenbacher, L.; Lister, T. A.; Kroll, S.; Wahl, R. L.; Knox, S. J.; more...
Blood (2004)

Fulltext@MSK | Save

Absence of inducible costimulator (ICOS) on alloreactive T cells reduces graft-versus-host-disease while leaving graft-versus-tumor activity intact

Meeting Abstract

Hubbard, V. M.; Eng, J. M.; Tjoe, K. H.; Ramirez-Montagut, T.; Muriglan, S. J.; Kochman, A. A.; Terwey, T. H.; Schiro, R.; Alpdogan, O.; van den Brink, M. R. M.
Blood (2004)

Fulltext@MSK | Save

Mechanisms of resistance to the FLT3-tyrosine kinase inhibitor PKC412 in patients with AML

Meeting Abstract

Heidel, F.; Breitenbuecher, F.; Kindler, T.; Solem, F. K.; Carius, B.; Thiede, H. M.; Cohen, P. S.; Roesel, J.; Estey, E. H.; Feldman, E.; more...
Blood (2004)

Fulltext@MSK | Save

Doxorubicin and dexamethasone followed by thalidomide and dexamethasone (AD-TD) as initial therapy for symptomatic patients with multiple myeloma

Meeting Abstract

Hassoun, H.; Reich, L.; Klimek, V. M.; Kewalramani, T.; Dhodapkar, M.; Drake, L.; Zimman, R.; Hedvat, C. V.; Teruya-Feldstein, J.; Fleisher, M.; more...
Blood (2004)

Fulltext@MSK | Save

Primary Mediastinal Large B cell Lymphoma: Elucidating optimal therapy and prognostic factors; an analysis in 141 consecutive patients treated at Memorial Sloan Kettering from 1980-1999

Meeting Abstract

Hamlin, P. A.; Portlock, C. S.; Straus, D. J.; Noy, A.; Horwitz, S. M.; O'connor, O.; Yahalom, J.; Zelenetz, A. D.; Moskowitz, C. H.
Blood (2004)

Fulltext@MSK | Save